Rates of Tuberculosis Transmission to Children and Adolescents in a Community with a High Prevalence of HIV Infection Among Adults

Overview

Journal Clin Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2008 Jun 19

PMID 18558885

Citations 48

Authors

Keren Middelkoop

Linda-Gail Bekker

Landon Myer

Rodney Dawson

Robin Wood

Affiliations

Soon will be listed here.

Abstract

Background: Tuberculin skin test surveys are routinely used to test for tuberculosis (TB) infection in communities, but there are few data from tuberculin skin test surveys from countries in which both TB and human immunodeficiency virus (HIV) infection are prevalent.

Methods: We conducted a tuberculin skin test survey among 831 school-going children aged 5-17 years in a community that was experiencing an increase in the prevalence of TB and HIV infection. Responses to purified protein derivative RT23 were measured 3 days after the test was administered to determine tuberculin skin test results.

Results: The prevalence of tuberculin skin test results positive for TB (i.e., an induration >or=10 mm in diameter in response to the skin test) ranged from 26.2% among children aged 5-8 years to 52.5% among children aged 14-17 years. The overall annual risk of infection was 4.1% using a 10-mm cutoff and 2.0% using a 17.4-mm cutoff. Annual risks of infection were constant across age groups. This is consistent with the finding that TB incidence remained the same in children (P= .48) from 1999 through 2005, although total TB incidence and adult TB (determined by sputum smear test) incidence increased in this community during the same period (P<.001).

Conclusions: The annual risk of infection is high in the community. It appears that HIV infection-associated TB is not a major influence on the annual risk of infection and that TB transmission from adults to children may be associated with a subset of TB cases in the community. An improved understanding of TB transmission patterns is urgently needed help the implementation of novel strategies for reducing the annual risk of infection in this setting.

Citing Articles

Tuberculin skin test surveys and the Annual Risk of Tuberculous Infection in school children in Northern KwaZulu-Natal.

Yates T, Cebekhulu S, Mthethwa M, Fourie P, Newell M, Abubakar I PLOS Glob Public Health. 2024; 4(6):e0003263.

PMID: 38889188 PMC: 11185501. DOI: 10.1371/journal.pgph.0003263.

Tuberculosis Immunoreactivity Surveillance in Malawi (Timasamala)-A protocol for a cross-sectional Mycobacterium tuberculosis immunoreactivity survey in Blantyre, Malawi.

Rickman H, Phiri M, Feasey H, Mbale H, Nliwasa M, Semphere R PLoS One. 2024; 19(5):e0291215.

PMID: 38787869 PMC: 11125513. DOI: 10.1371/journal.pone.0291215.

Challenges of Diagnosing Mendelian Susceptibility to Mycobacterial Diseases in South Africa.

Scholtz D, Jooste T, Moller M, van Coller A, Kinnear C, Glanzmann B Int J Mol Sci. 2023; 24(15).

PMID: 37569495 PMC: 10418440. DOI: 10.3390/ijms241512119.

Direct estimates of absolute ventilation and estimated Mycobacterium tuberculosis transmission risk in clinics in South Africa.

Beckwith P, Karat A, Govender I, Deol A, McCreesh N, Kielmann K PLOS Glob Public Health. 2023; 2(11):e0000603.

PMID: 36962521 PMC: 10021606. DOI: 10.1371/journal.pgph.0000603.

Tuberculosis in Adolescents in Bulgaria for a Three-Year Period: 2018-2020.

Gabrovska N, Spasova A, Galacheva A, Kostadinov D, Yanev N, Milanov V Children (Basel). 2022; 9(6).

PMID: 35740721 PMC: 9221996. DOI: 10.3390/children9060785.

References

Rieder H . Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys. Tuber Lung Dis. 1995; 76(2):114-21. DOI: 10.1016/0962-8479(95)90552-9. View

De Cock K, Chaisson R . Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis. 1999; 3(6):457-65. View

Espinal M, Perez E, Baez J, Henriquez L, Fernandez K, Lopez M . Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. Lancet. 2000; 355(9200):275-80. DOI: 10.1016/S0140-6736(99)04402-5. View

Lawn S, Bekker L, Middelkoop K, Myer L, Wood R . Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. Clin Infect Dis. 2006; 42(7):1040-7. DOI: 10.1086/501018. View

Wood R, Middelkoop K, Myer L, Grant A, Whitelaw A, Lawn S . Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med. 2006; 175(1):87-93. PMC: 1899262. DOI: 10.1164/rccm.200606-759OC. View

Friedland I . The booster effect with repeat tuberculin testing in children and its relationship to BCG vaccination. S Afr Med J. 1990; 77(8):387-9. View

Menzies D . What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us?. Clin Infect Dis. 2000; 31 Suppl 3:S71-4. DOI: 10.1086/314075. View

Cayla J, Garcia de Olalla P, Galdos-Tanguis H, Vidal R, Lopez-Colomes J, Gatell J . The influence of intravenous drug use and HIV infection in the transmission of tuberculosis. AIDS. 1996; 10(1):95-100. DOI: 10.1097/00002030-199601000-00014. View

Grindulis H, Baynham M, Scott P, Thompson R, Wharton B . Tuberculin response two years after BCG vaccination at birth. Arch Dis Child. 1984; 59(7):614-9. PMC: 1628956. DOI: 10.1136/adc.59.7.614. View

10.

Menzies D . Tuberculin surveys--why?. Int J Tuberc Lung Dis. 1998; 2(4):263-4. View

11.

Whalen C . Failure of directly observed treatment for tuberculosis in Africa: a call for new approaches. Clin Infect Dis. 2006; 42(7):1048-50. DOI: 10.1086/501022. View

12.

Lawn S, Bangani N, Vogt M, Bekker L, Badri M, Ntobongwana M . Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect Dis. 2007; 7:99. PMC: 2031899. DOI: 10.1186/1471-2334-7-99. View

13.

Arabin G, Gartig D, Kleeberg H . First tuberculosis prevalence survey in KwaZulu. S Afr Med J. 1979; 56(11):434-8. View

14.

Jaspan H, Berwick J, Myer L, Mathews C, Flisher A, Wood R . Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials. J Adolesc Health. 2006; 39(5):642-8. DOI: 10.1016/j.jadohealth.2006.05.016. View

15.

Rangaka M, Wilkinson K, Seldon R, Van Cutsem G, Meintjes G, Morroni C . Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med. 2006; 175(5):514-20. DOI: 10.1164/rccm.200610-1439OC. View

16.

. B.C.G. and Vole Bacillus Vaccines in the Prevention of Tuberculosis in Adolescence and Early Adult Life. Br Med J. 2010; 1(5336):973-8. PMC: 2122882. View

17.

Rieder H . Annual risk of infection with Mycobacterium tuberculosis. Eur Respir J. 2005; 25(1):181-5. DOI: 10.1183/09031936.04.00103804. View

18.

Egwaga S, Cobelens F, Muwinge H, Verhage C, Kalisvaart N, Borgdorff M . The impact of the HIV epidemic on tuberculosis transmission in Tanzania. AIDS. 2006; 20(6):915-21. DOI: 10.1097/01.aids.0000218557.44284.83. View

19.

Arnadottir T, Rieder H, Trebucq A, Waaler H . Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tuber Lung Dis. 1996; 77 Suppl 1:1-19. DOI: 10.1016/s0962-8479(96)90127-6. View

20.

Carvalho A, DeRiemer K, Nunes Z, Martins M, Comelli M, Marinoni A . Transmission of Mycobacterium tuberculosis to contacts of HIV-infected tuberculosis patients. Am J Respir Crit Care Med. 2001; 164(12):2166-71. DOI: 10.1164/ajrccm.164.12.2103078. View